{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,27]],"date-time":"2023-08-27T06:42:24Z","timestamp":1693118544990},"edition-number":"1","reference-count":34,"publisher":"Wiley","isbn-type":[{"value":"9780470663851","type":"print"},{"value":"9780470720578","type":"electronic"}],"license":[{"start":{"date-parts":[[1980,1,1]],"date-time":"1980-01-01T00:00:00Z","timestamp":315532800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1980,1]]},"DOI":"10.1002\/9780470720578.ch8","type":"other","created":{"date-parts":[[2008,5,30]],"date-time":"2008-05-30T12:53:03Z","timestamp":1212151983000},"page":"115-139","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Significance of Monitoring Plasma Levels of Psychotropic Drugs"],"prefix":"10.1002","author":[{"given":"Paolo Lucio","family":"Morselli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard","family":"Zarifian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,5,30]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"807","article-title":"Haloperidol: twenty years\u2019 clinical experience","volume":"39","author":"Ayd FJ","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_3_1","first-page":"326","volume-title":"GABA and neurotransmitters.","author":"Bartholini G","year":"1979"},{"key":"e_1_2_1_4_1","article-title":"Influence of route of administration on haloperidol plasma levels in psychotic patients","volume":"17","author":"Bianchetti G","year":"1980","journal-title":"J Clin Pharmacol Biopharm:"},{"key":"e_1_2_1_5_1","first-page":"766","article-title":"A guide to the use of psychotropic medication in children and adolescents","volume":"39","author":"Blau S","year":"1978","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-197803010-00002"},{"key":"e_1_2_1_7_1","first-page":"9","article-title":"Individual variability in response to haloperidol","volume":"69","author":"Forsman AD","year":"1976","journal-title":"Proc R SOC Med"},{"key":"e_1_2_1_8_1","first-page":"396","article-title":"Applied pharmacokinetics of haloperidol in man","volume":"21","author":"Forsman AO","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_9_1","first-page":"24179","article-title":"On the objective evaluation of haloperidol effects in man","author":"Forsman AO","year":"1978","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1978.01770340072008"},{"key":"e_1_2_1_11_1","first-page":"277","volume-title":"Clinical pharmacology and clinical pharmacy.","author":"Morselli PL","year":"1976"},{"key":"e_1_2_1_12_1","volume-title":"Drug disposition during development.","author":"Morselli PL","year":"1977"},{"key":"e_1_2_1_13_1","first-page":"877","volume-title":"Neuropsychopharmacology.","author":"Morselli PL","year":"1978"},{"key":"e_1_2_1_14_1","first-page":"555","volume-title":"Proceedings XI CINP Congress. Vienna, July 1978.","author":"Morselli PL","year":"1979"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1159\/000402275"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691-197901000-00004"},{"key":"e_1_2_1_17_1","volume-title":"Proceedings X Epilepsy International Symposium. Vancouver, Sept. 1978.","author":"Morselli PL","year":"1980"},{"key":"e_1_2_1_18_1","volume-title":"Long\u2010term effects of neuroleptics.","author":"Morselli PL","year":"1980"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1973146978"},{"key":"e_1_2_1_20_1","first-page":"215","article-title":"Correlation between plasma concentrations of chlorpromazine and clinical response","volume":"2","author":"Rivera\u2010Calimlim L","year":"1978","journal-title":"Commun Psychopharmacol"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00426804"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(77)90230-8"},{"key":"e_1_2_1_23_1","volume-title":"Long\u2010term effects of neuroleptics.","author":"Scatton B","year":"1980"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.134.5.470"},{"key":"e_1_2_1_25_1","first-page":"8","article-title":"Therapeutic antagonism between neuroleptics and anticholinergic antiparkinson agents in schizophrenia","volume":"2","author":"Singh NM","year":"1974","journal-title":"J Bronx State Hosp"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1979.01780050089011"},{"key":"e_1_2_1_27_1","unstructured":"Symposium on haloperidok a new profile?(1976). Proc R Soc Med 69 Suppl. 1:144"},{"key":"e_1_2_1_28_1","first-page":"6407","article-title":"Clinical significance of plasma chlorpromazine levels: plasma levels of the drug, some of its metabolites and prolactin during acute treatment","author":"Wiles DH","year":"1976","journal-title":"Psychol Med"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1978233303"},{"key":"e_1_2_1_30_1","first-page":"297","article-title":"Thymoleptic and neuroleptic drug plasma levels in psychiatry: current status","volume":"19","author":"Cooper TB","year":"1976","journal-title":"Int Rev Neurobiol"},{"key":"e_1_2_1_31_1","first-page":"9","article-title":"Individual variability in response to haloperidol","volume":"69","author":"Forsman AD","year":"1976","journal-title":"Proc R Soc Med"},{"key":"e_1_2_1_32_1","first-page":"396","article-title":"Applied pharmacokinetics of haloperidol in man","volume":"21","author":"Forsman AO","year":"1977","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_33_1","first-page":"179","article-title":"On the objective evaluation of haloperidol effects in man","volume":"24","author":"Forsman AO","year":"1978","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_34_1","first-page":"29","article-title":"Dosage adjustment from simple nortriptyline predictor test in depressed patients","volume":"41","author":"Montgomery S","year":"1979","journal-title":"Clin Pharmacokinet"},{"key":"e_1_2_1_35_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1094490"}],"container-title":["Novartis Foundation Symposia","Ciba Foundation Symposium 74 \u2010 Drug Concentrations in Neuropsychiatry"],"original-title":[],"link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2F9780470720578.ch8","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/9780470720578.ch8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,26]],"date-time":"2023-08-26T10:37:08Z","timestamp":1693046228000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/9780470720578.ch8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1980,1]]},"ISBN":["9780470663851","9780470720578"],"references-count":34,"alternative-id":["10.1002\/9780470720578.ch8","10.1002\/SERIES1767","10.1002\/9780470720578"],"URL":"https:\/\/doi.org\/10.1002\/9780470720578.ch8","archive":["Portico"],"relation":{},"ISSN":["1935-4657"],"issn-type":[{"value":"1935-4657","type":"electronic"}],"subject":[],"published":{"date-parts":[[1980,1]]}}}